QuantRx Biomedical Corporation
QTXB
$0.0005
$0.0003150.00%
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.90K | 1.60K | 5.90K | 6.00K | 21.10K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.50K | 3.00K | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 5.40K | 4.60K | 5.90K | 6.00K | 21.10K |
|
|
|||||
| Total Current Assets | 5.40K | 4.60K | 5.90K | 6.00K | 21.10K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 5.40K | 4.60K | 5.90K | 6.00K | 21.10K |
|
|
|||||
| Total Accounts Payable | 16.50K | 14.50K | 13.80K | 10.20K | 18.80K |
| Total Accrued Expenses | 1.31M | 1.17M | 1.12M | 1.07M | 1.02M |
| Short-term Debt | 1.52M | 1.60M | 1.57M | 1.57M | 1.57M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.85M | 2.78M | 2.70M | 2.65M | 2.60M |
|
|
|||||
| Total Current Liabilities | 2.85M | 2.78M | 2.70M | 2.65M | 2.60M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.52M | 1.60M | 1.57M | 1.57M | 1.57M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.85M | 2.78M | 2.70M | 2.65M | 2.60M |
|
|
|||||
| Common Stock & APIC | 49.66M | 49.66M | 49.66M | 49.66M | 49.66M |
| Retained Earnings | -52.57M | -52.51M | -52.43M | -52.38M | -52.31M |
| Treasury Stock & Other | 8.60K | 8.60K | 8.60K | 8.60K | 8.60K |
| Total Common Equity | -2.90M | -2.84M | -2.76M | -2.70M | -2.64M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 62.00K | 62.00K | 62.00K | 62.00K | 62.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 62.00K | 62.00K | 62.00K | 62.00K | 62.00K |
|
|
|||||
| Total Common Equity | -2.90M | -2.84M | -2.76M | -2.70M | -2.64M |
| Total Preferred Equity | 62.00K | 62.00K | 62.00K | 62.00K | 62.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.84M | -2.78M | -2.70M | -2.64M | -2.58M |
|
|
|||||
